ArticleInternational journal of chronic obstructive pulmonary disease2025
Application Study of Health Management Model Based on Traditional Chinese Medicine Constitution Identification in COPD Patients: A Retrospective Analysis.
Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- UHPLC -Q-Orbitrap HRMS Integrated with Network Pharmacology Reveals the Anti-COPD Mechanism of Jianzhong Peiyuan Decoction and Functional Validation of Core Component Luteolin.Journal of inflammation research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Objective: This retrospective study aimed to evaluate a health management model based on traditional Chinese medicine (TCM) constitution identification in Chronic Obstructive Pulmonary Disease (COPD) patients. Methods: This retrospective case-control study selected 108 COPD patients from the Respiratory Department of our hospital, divided into an observation group (n=54, receiving TCM constitution-based health management) and a control group (n=54, receiving routine health guidance). Primary outcome measures included COPD Assessment Test (CAT) scores and Forced Expiratory Volume in one second (FEV1). Results: After 6 months, the observation group showed improvements in CAT scores (baseline: 24.93±2.61 to 6 months: 22.31±2.12, p<0.001) and FEV1 values (baseline: 1.34±0.71 L to 6 months: 1.79±0.73 L, p<0.001). After propensity score matching, clinical response rates remained higher in the observation group (CAT: 48.8% vs 18.6%; FEV1: 72.1% vs 7.0%, both p<0.001). However, significant baseline differences existed between groups, with the observation group being younger, having shorter disease duration, and better baseline lung function (all GOLD II vs 55.6% GOLD III in controls). Conclusion: This retrospective study provides preliminary evidence suggesting potential value of TCM constitution-based health management in COPD patients. However, significant baseline differences and methodological limitations necessitate cautious interpretation. Well-designed prospective randomized controlled trials with matched cohorts are essential to establish efficacy definitively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.